QSAR and Molecular Docking of Phthalazine Derivatives as Epidermal Growth Factor Receptor (EGFR) Inhibitors
Monika G. Shinde, Siddharth J. Modi, Vithal M. Kulkarni
DOI: 10.7324/JAPS.2017.70427Pages: 181-191
3D-QSAR analysis of pyrimidine derivatives as AXL kinase inhibitors as anticancer agents
Siddharth J. Modi, Vithal M. Kulkarni
DOI: 10.7324/JAPS.2018.81103Pages: 015-027
3D-QSAR, molecular docking, and dynamics simulation of quinazoline–phosphoramidate mustard conjugates as EGFR inhibitor
Ruslin Ruslin, Resky Amelia, Yamin Yamin, Sandra Megantara, Chun Wu, Muhammad Arba
DOI: 10.7324/JAPS.2019.90113Pages: 089-097
3D-QSAR, molecular docking and dynamics simulation of difluorophenol pyridine derivatives as RSK2 inhibitor
Muhammad Arba, Hamzah Azali, Sabarudin Ombe, Alrum Armid, Ida Usman
DOI: 10.7324/JAPS.2019.90601Pages: 001-009
3D QSAR and docking studies on benzoylsulfonohydrazides as histone acetyltransferase KAT6A inhibitors
MD. Muzaffar-Ur-Rehman, Syed Akbar, Asra Ali Bahazeq
DOI: 10.7324/JAPS.2020.10504Pages: 023-030
Insights into the structural features of anticancer 1,6-naphthyridines and pyridopyrimidines as VEGFR-2 inhibitors: 3D-QSAR study
Siddharth J. Modi, Dharti H. Modh, Vithal M. Kulkarni
DOI: 10.7324/JAPS.2020.10101Pages: 001-022
